Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. The firm's strategy centers on advancing innovative treatments for severe diseases to impact patients’ lives. They focus on backing great teams with development programs that can make a true difference for patients.
Bevorzugte Reifephase für die erste Finanzierung.
Drug development, Biological drugs, Novel therapeutics, Oncology, Fibrotic diseases, Neurological diseases, Respiratory diseases, Inflammatory diseases, Heart failure, Kidney injury
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...